Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Oxytocin in the Treatment of Autism

NCT00490802 is registered in ClinicalTrials.gov with Evdokia Anagnostou as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00490802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Oxytocin in the Treatment of Autism
Lead sponsor
Evdokia Anagnostou
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2006
Completion date
April 30, 2012
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism